ADAPTIVE BIOTECHNOLOGIES CORPORATION: accounts_receivable
| Value | {"amount": 9382000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-03-31) |
| Status | current |
| Entity | ADAPTIVE BIOTECHNOLOGIES CORPORATION |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:40:38.348801+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b1dbb48c-b34c-43ac-ad2a-2753940ab489
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-20-024687Retrieved: 2026-08-19T14:40:38.348801+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001478320/accounts-receivable/2020-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b1dbb48c-b34c-43ac-ad2a-2753940ab489
History
- no predecessors — first report